Half Year 2026 Tetragon Financial Group Ltd Earnings Call Transcript
Key Points
- Tetragon Financial Group Ltd (LSE:TFG) successfully completed the sale of its BGO stake, receiving $294.5 million from the exercised call option and an additional $155 million for relinquishing ongoing rights, both above previous marks.
- The company's investment in Equitix generated a gain of $34.4 million and a dividend of $17.9 million, with the valuation increasing by 1% due to higher EBITDA.
- Tetragon Life Sciences Fund showed strong performance, generating a gain of $46.2 million in the first half, with $141 million invested and $115 million returned from sales.
- The company maintains a strong alignment of interest with shareholders, as principals and employees own 42.2% of public shares, up from 39.4% at the end of last year.
- Tetragon Financial Group Ltd (LSE:TFG) continues to return value to shareholders through dividends and share repurchases, with an annualized yield of approximately 3.6% and $71.8 million spent on buybacks in the first half.
- Tetragon Financial Group Ltd (LSE:TFG) reported a negative NAV per share total return of 2.5% and a negative return on equity of 4.5% for the first half of 2026, below its target range and long-term average.
- The company's investment in Ripple Labs suffered a significant loss of $138.9 million, driven by a decline in the private market price from $150 to $109 per share.
- Other equities, particularly UiPath, experienced a loss of $69.2 million due to mark-to-market losses amid sector-wide multiple compression.
- The decision to exit the CLO management space resulted in a loss of $63.8 million from LCM, with the sale of management contracts for only $40.5 million upfront.
- The company's net cash position is negative at $135.8 million, with $185 million drawn on its revolving credit facility, reflecting high leverage and cash commitments.
(Operator Instructions)
I'll now turn you over to Patty Deer to commence the presentation.
As one of the principals and founders. Of the Investment Manager of Tetragon Financial Group Limited. I'd like to welcome you to our investor call, where we will focus on the company's 2026 first half results. Paul Gannon, our CFO and CEO, is actually unable to participate in today's call, so I will review the company's financial performance for the period. And then Steve Prince and I will talk you through some of the detail of the portfolio and performance.
Before I go into the presentation, some reminders. First, Tetragon shares are subject to restrictions on ownership by US persons and are not intended for European retail investors, and these are described on our website.
Tetragon anticipates that its typical investors will be institutional and professional investors who wish to invest for the long-term and who have experience in investing in financial markets and collective investment
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
